Russia Claims to Have a Cancer Vaccine. Is It Ready to Use?

Watch Russia Claims to Have a Cancer Vaccine. Is It Ready to Use? - Rizzle on Dailymotion

Transcript

00:00Russia claims to have a cancer vaccine. Is it ready to use? Russian scientists announce

00:06Enteromix, an mRNA-based cancer vaccine, showing 100% efficacy in preclinical trials. Experts note

00:14it's an early breakthrough but stress the results aren't yet confirmed in full human trials.

00:22Enteromix is a personalized mRNA cancer vaccine that trains the immune system to target tumor

00:28cells. By delivering genetic instructions, it enables cells to make antigens that trigger antibodies

00:33against cancer while sparing healthy tissue, per telegraph agency of the USSR.

00:43Professor Sayao Ming Li of University College London Hospitals told First Post that mRNA offers

00:49a simple way to deliver targeted antigens in cancer cells, calling it the next big phase of cancer

00:55treatment. Enteromix, developed after years of research and preclinical tests, shrank or slowed

01:03tumors by 60 to 80 percent in some cases. First targeting colorectal cancer, it's also being

01:09studied for glioblastoma and melanoma. Experts stress the 100% efficacy claim is only from preclinical data.

01:16Russia isn't alone in cancer vaccine research. The UK's NHS and BioNTech have launched the cancer vaccine launch pad,

01:27while the US has already approved one for prostate cancer.

01:34Enteromix is a promising step in cancer immunotherapy, but evidence so far is limited to preclinical data.

01:40If future trials confirm results, it could transform treatment, though for now it remains experimental under regulatory review.